SGO Journal Club: Controversial Topics in Gynecologic Cancer: Heated Intraperitoneal Chemotherapy
Join members of the SGO Education and Clinical Practice Committees for the inaugural session of the SGO Journal Club, Controversial Topics in Gynecologic Cancer: Heated Intraperitoneal Chemotherapy (HIPEC), to hear pros, cons, and first-hand experience from guest speakers followed by casual discussion. The Journal Club is designed to bring SGO members together to learn and discuss key topics in gynecologic oncology with the support of key literature, and provide a forum to connect with colleagues. Attendees are invited to stick around after the HIPEC discussion to network and socialize with their peers.
HIPEC at the time of tumor debulking for ovarian cancer has at least one randomized prospective trial demonstrating benefit in overall survival. There is conflicting data as to the approach and timing of HIPEC. Concerns exist regarding toxicity and complexity of use. Significant heterogeneity exists amongst providers whether HIPEC is even discussed as a treatment option with patients.
- Susan Zweizig, MD, UMass Memorial Health Care
- Renata Urban, MD, University of Washington
- Chad Michener, MD, Cleveland Clinic
- Michael McHale, MD, University of California San Diego Health